Distress among women receiving uninformative BRCA1/2 results: 12‐month outcomes
- 12 February 2009
- journal article
- research article
- Published by Wiley in Psycho-Oncology
- Vol. 18 (10) , 1088-1096
Abstract
Objective: Few data are available regarding the long‐term psychological impact of uninformative BRCA1/2 test results. This study examines change in distress from pretesting to 12‐months post‐disclosure, with medical, family history, and psychological variables, such as pretesting perceived risk of carrying a deleterious mutation prior to testing and primary and secondary appraisals, as predictors.Methods: Two hundred and nine women with uninformative BRCA1/2 test results completed questionnaires at pretesting and 1‐, 6‐, and 12‐month post‐disclosure, including measures of anxiety and depression, cancer‐specific and genetic testing distress. We used a mixed models approach to predict change in post‐disclosure distress.Results: Distress declined from pretesting to 1‐month post‐disclosure, but remained stable thereafter. Primary appraisals predicted all types of distress at 1‐month post‐disclosure. Primary and secondary appraisals predicted genetic testing distress at 1‐month as well as change over time. Receiving a variant of uncertain clinical significance and entering testing with a high expectation for carrying a deleterious mutation predicted genetic testing distress that persisted through the year after testing.Conclusions: As a whole, women receiving uninformative BRCA1/2 test results are a resilient group. For some women, distress experienced in the month after testing does not dissipate. Variables, such as heightened pretesting perceived risk and cognitive appraisals, predict greater likelihood for sustained distress in this group and could be amenable to intervention. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 46 references indexed in Scilit:
- Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancerFamilial Cancer, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Quality of Life After Contralateral Prophylactic Mastectomy in Newly Diagnosed High-Risk Breast Cancer Patients Who Underwent BRCA1/2 Gene TestingJournal of Clinical Oncology, 2007
- Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivorsBreast Cancer Research and Treatment, 2006
- Tolerance for uncertainty and perceived risk among women receiving uninformativeBRCA1/2test resultsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2006
- Screening behavior in women at increased familial risk for breast cancerFamilial Cancer, 2006
- Decision making and decision support for hereditary breast-ovarian cancer susceptibility.Health Psychology, 2005
- What do ratings of cancer‐specific distress mean among women at high risk of breast and ovarian cancer?American Journal of Medical Genetics Part A, 2002
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerNature Genetics, 1996